Assessment of MGMT promoter methylation status in glioblastoma using deep learning features from multi-sequence MRI of intratumoral and peritumoral regions
Abstract Objective This study aims to evaluate the effectiveness of deep learning features derived from multi-sequence magnetic resonance imaging (MRI) in determining the O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status among glioblastoma patients. Methods Clinical, patholog...
Saved in:
| Main Authors: | Xuan Yu, Jing Zhou, Yaping Wu, Yan Bai, Nan Meng, Qingxia Wu, Shuting Jin, Huanhuan Liu, Panlong Li, Meiyun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cancer Imaging |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40644-024-00817-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
by: ZHANG Zhi-zhong, et al.
Published: (2025-07-01) -
Prediction of MGMT methylation status in glioblastoma patients based on radiomics feature extracted from intratumoral and peritumoral MRI imaging
by: Wang-Sheng Chen, et al.
Published: (2025-07-01) -
O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
by: Müge Sak, et al.
Published: (2025-04-01) -
Corrigendum: O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
by: Müge Sak, et al.
Published: (2025-06-01) -
Status of temozolomide use without insurance coverage in patients with aggressive pituitary neuroendocrine tumors
by: Atsushi Ishida, et al.
Published: (2025-07-01)